Vitiligo treated successfully with arthritis drug and light therapy

January 31, 2018, Yale University

Building on prior research that examined the use of an arthritis medication to treat vitiligo, a team of Yale dermatologists has successfully applied a novel combination therapy—the medication and light—to restore skin color in patients.

The study, led by associate professor of dermatology Brett King, M.D., was published in JAMA Dermatology on January 31, 2018.

King and his colleagues reported two cases of patients with significant loss of skin color from vitiligo, a that destroys skin pigment, leaving white splotches where there had been color. For King's patients, standard treatments, such as steroid creams and light treatment, had failed to restore pigmentation. To address these difficult cases, the research team combined the medication, tofacitinib, with narrow band ultraviolet B light therapy. In recent experiments, King and Dr. John Harris, a dermatologist at University of Massachusetts-Worcester, had shown that tofacitinib keeps the immune system from attacking the skin cells that manufacture (color), and light stimulates pigment-making cells to restore color to the skin.

After a few months of the combination therapy, there was remarkable improvement, report the researchers: One patient saw near-total restoration of on her face, neck, chest, forearms, and shins. The other patient experienced similar success.

While more research is needed, the study highlights another advance by the Yale team in treating this and other stigmatizing skin conditions. "These findings will define treatment of vitiligo in the future," King said.

Explore further: For vitiligo patient, arthritis drug restores skin color

Related Stories

For vitiligo patient, arthritis drug restores skin color

June 24, 2015
A medication for treating rheumatoid arthritis has restored skin color in a patient suffering from vitiligo, according to dermatologists at Yale School of Medicine. The disfiguring condition is best known as the disease that ...

MKTP surgery has long-term benefit for restoring skin pigmentation in vitiligo patients

July 27, 2017
A Henry Ford Hospital study has shown that skin transplant surgery has long-term benefit for restoring skin pigmentation caused by the skin disease vitiligo.

Researchers beat untreatable eczema with arthritis drug

July 20, 2015
Researchers at Yale School of Medicine have successfully treated patients with moderate to severe eczema using a rheumatoid arthritis drug recently shown to reverse two other disfiguring skin conditions, vitiligo and alopecia ...

Vitiligo treatment holds promise for restoring skin pigmentation

September 17, 2014
A treatment regimen is safe and effective for restoring skin pigmentation in vitiligo patients, according to a Henry Ford Hospital study.

Skin cell transplant may offer new hope to vitiligo patients

June 22, 2012
(HealthDay) -- Skin cell transplants can restore pigment to the skin of some patients with the disorder known as vitiligo, new research finds.

Skin transplant offers new hope for vitiligo patients

May 30, 2012
Henry Ford Hospital dermatologists say skin transplant surgery is safe and effective for restoring skin pigmentation caused by the skin disease vitligo.

Recommended for you

Whether the donor and recipient are male or female influences transplant rejection rates—investigators explore why

March 22, 2018
Biological sex differences can have far-reaching, clinical consequences, as illustrated by organ transplant outcomes. Men and women who receive donated organs can have different rates of transplant rejection, in some cases ...

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Mumps resurgence likely due to waning vaccine-derived immunity

March 21, 2018
A resurgence of mumps in the U.S. among vaccinated young adults appears to be due to waning of vaccine-induced immunity, according to a new analysis from Harvard T.H. Chan School of Public Health. Researchers found that vaccine-derived ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.